ACTON, Mass.--(BUSINESS WIRE)--Feb. 19, 2019--
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless
insulin pump technology with its Omnipod® Insulin
Management System, today announced that management will present at three
upcoming investor conferences:
- The Raymond James & Associates' 40th Annual
Institutional Investors Conference in Orlando, Florida on Tuesday,
March 5, 2019, at 2:50 p.m. (Eastern Time).
- The Cowen and Company 39th Annual Health Care Conference in
Boston, Massachusetts on Tuesday, March 12, 2019, at 12:00 p.m.
- The Barclays Global Healthcare Conference in Miami, Florida on
Thursday, March 14, 2019, at 8:30 a.m. (Eastern Time).
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com.
Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is
an innovative medical device company dedicated to making the lives of
people with diabetes and other conditions easier through the use of its
Omnipod product platform. The Omnipod Insulin Management System provides
a unique alternative to traditional insulin delivery methods. With its
simple, wearable design, the disposable Pod provides up to three days of
non-stop insulin delivery, without the need to see or handle a needle.
Insulet also leverages the unique design of its Pod by tailoring its
Omnipod technology platform for the delivery of non-insulin subcutaneous
drugs across other therapeutic areas. Founded in 2000, Insulet has more
than 150,000 users across the globe who rely on its Omnipod Insulin
Management System to bring simplicity and freedom to their lives.
For more information, please visit: www.insulet.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190219005877/en/
Source: Insulet Corporation
Investor Relations and Media Contact:
Vice President, Investor Relations and Corporate